Between agitation and nausea/vomiting, olanzapine has a wide range of use.
Olanzapine is generally not a front-line agent (e.g., haloperidol or ondansetron often are). But sometimes, it really comes in clutch....
Between agitation and nausea/vomiting, olanzapine has a wide range of use.
Olanzapine is generally not a front-line agent (e.g., haloperidol or ondansetron often are). But sometimes, it really comes in clutch....
criticalcarereviews.com/latest-evide...
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2025
criticalcarereviews.com/latest-evide...
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2025
-Augments GABA, inhibits glutamate
-Option 1: no BZD given. 10 mg/kg IV over 30 min. Can redose 2-3 times
-Option 2: BZD given. Load 130 mg IV q15 until sedation
-Early phenobarbital use can avoid intubation + general anesthesia
#MedSky #EMIMCC
youtube.com/shorts/WDBbp...
-Augments GABA, inhibits glutamate
-Option 1: no BZD given. 10 mg/kg IV over 30 min. Can redose 2-3 times
-Option 2: BZD given. Load 130 mg IV q15 until sedation
-Early phenobarbital use can avoid intubation + general anesthesia
#MedSky #EMIMCC
youtube.com/shorts/WDBbp...
(I know, I know. What can I say, I'm a true internist!)
HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary!
Here are my top 10 hyponatremia tips and tricks - a 🧵
#emimcc
(I know, I know. What can I say, I'm a true internist!)
HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary!
Here are my top 10 hyponatremia tips and tricks - a 🧵
#emimcc
CCR Journal Watch
criticalcarereviews.com/latest-evide...
Get the latest critical care literature every weekend via the CCR Newsletter - subscribe at criticalcarereviews.com/newsletters/...
CCR Journal Watch
criticalcarereviews.com/latest-evide...
Get the latest critical care literature every weekend via the CCR Newsletter - subscribe at criticalcarereviews.com/newsletters/...